---
document_datetime: 2023-11-15 10:11:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rebetol-epar-all-authorised-presentations_en.pdf
document_name: rebetol-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1427319
conversion_datetime: 2025-12-22 20:41:52.996857
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging             | Content   | Package size                |
|-----------------|-----------------|------------|-----------------------|---------------------------|-----------------------|-----------|-----------------------------|
| EU/1/99/107/001 | Rebetol         | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC) |           | 84 hard capsules authorised |
| EU/1/99/107/002 | Rebetol         | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC) |           | 140 hard capsules           |
| EU/1/99/107/003 | Rebetol         | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC) |           | 168 hard capsules           |
| EU/1/99/107/004 | Rebetol         | 40 mg/ml   | Oral solution         | Oral use                  | bottle (glass)        | 100 ml    | 1 bottle                    |
| EU/1/99/107/005 | Rebetol         | 200 mg     | Capsule, hard         | Oral use                  | blister (PVC/PE/PVDC) |           | 112 hard capsules           |

Medicinal product no longer authorised